Pimavanserin reduced dementia-related psychotic symptoms without affecting cognitionDecember 13, 2019Alzheimer's & CognitionParkinson's DiseaseMovement Disorders
Parkinson’s patients can lose swimming ability after deep brain stimulationDecember 3, 2019Parkinson's DiseaseMovement Disorders
Antibiotic use may increase the risk of Parkinson’s diseaseDecember 3, 2019Parkinson's DiseaseMovement DisordersMixed Topics
FDA approves onabotulinumtoxinA for pediatric lower limb spasticityOctober 24, 2019Movement DisordersPediatrics
Increased Parkinson’s disease risk seen with bipolar disorderOctober 14, 2019Parkinson's DiseaseMovement Disorders
FDA expands Dysport’s upper-limb spasticity indication to childrenSeptember 27, 2019Movement DisordersPediatrics
FDA approves istradefylline for Parkinson’s diseaseAugust 28, 2019Parkinson's DiseaseMovement Disorders
Anticholinergic drugs linked to dementia in older populationsJune 24, 2019Alzheimer's & CognitionParkinson's DiseaseEpilepsy & SeizuresMovement Disorders
CSF neurofilament light level could aid in diagnosisJune 18, 2019Alzheimer's & CognitionMovement DisordersParkinson's DiseaseMultiple Sclerosis
Treatment for hepatitis C reduces risk of Parkinson’s diseaseJune 6, 2019Parkinson's DiseaseMovement Disorders
Deutetrabenazine benefit may increase over time in patients with tardive dyskinesiaMay 11, 2019Movement Disorders
Appendectomy linked to increased risk of subsequent Parkinson’sMay 9, 2019Parkinson's DiseaseMovement Disorders
Patients describe significant impact of epilepsy on their livesMay 7, 2019Epilepsy & SeizuresMovement Disorders
